Genome Editing Technology

Selected news for the healthcare topic - Genome Editing Technology, collected since 10/2017. Recent stories appear in BioWorld and asco.org. This healthcare topic shares news with CRISPR, Precision BioSciences, Biotech and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/4/2021 Astronauts Genome Editing on ISS Investigating Regeneration of Damaged Cells Causing Cancer hngn.com ... experiment to document cells in the process of fixing cells ravaged by cancer cells. Astronauts used yeast cells as the guinea pig for the process, reported the Daily Mail. The method called CRISPR/Cas9 genome editing technology is used on animals and plants with precise results. This experiment in space will be done with a twist. Experiments on the ISS One of the objectives that will take advantage of the ...
4/12/2021 Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes biomedcentral.com ... sequencing for identification of single nucleotide variants (SNVs) and copy number variants (CNVs) in ATAD3A in individuals with neurological and mitochondrial phenotypes. A Drosophila Atad3a Gal4 knockin-null allele was generated using CRISPR-Cas9 genome editing technology to aid the interpretation of variants. Results We report 13 individuals from 8 unrelated families with biallelic ATAD3A variants. The variants included four missense variants inherited in trans to loss-of-function alleles ...
3/30/2021 Qihan raises $67M to advance cell and organ therapies in China 30 BioWorld Qihan Biotechology Co. Ltd., a company known for its multiplexable genome editing technology , has yet again extended its series A financing, this time with a $67 million round that will support advancement of its allogeneic cell therapy candidates to IND in China. To date the company has raised more than $100 million ...
3/30/2021 Re-Engineering the Health Care Code: The Reality of Genetic Codes and Zip Codes in the Context of Social Determinants of Health asco.org ... acknowledge that many tremendous scientific advancements have become attainable due to the fields of genetics, epigenetics, and scientific inquiry of basic science processes in these areas, with the latest successes of CRISPR-Cas9 and genome editing technology as key examples.2 However, a sad and often neglected reality is that zip code, more so than genetic code, is a fundamental factor driving many patient outcomes including mortality.3 Zip codes ...
3/29/2021 Qihan Biotech Raises Additional USD 67 Million in Series A++ Financing | Business Wire Business Wire HANGZHOU, China- Qihan Biotechnology Co. Ltd (“Qihan” or “the Company”), a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that it has raised an additional $67 million in Series A++ financing. Proceeds from the financing will primarily be used to advance Qihan ’s pipeline of novel cell therapies in IND-enabling studies and hypoimmunity projects, and expansion of the company’s ...
3/29/2021 Qihan Biotech Raises Additional USD 67 Million in Series A++ Financing financialbuzz.com Qihan Biotechnology Co. Ltd (“Qihan” or “the Company”), a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that it has raised an additional $67 million in Series A++ financing. Proceeds from the financing will primarily be used to advance Qihan ’s pipeline of novel cell therapies in IND-enabling studies and hypoimmunity projects, and expansion of the company’s GMP manufacturing ...
3/24/2021 Kochi firm develops technology to use genome editing in crops with genetic modification thehindubusinessline.com ó Changes tomato colour into yellow using Nobel Prize winners‚Äô methodA group of scientists at AgriGenome Labs in Kerala‚Äôs Kochi city has used the popular genome editing technology - CRISPR Cas9 - to change the colour of tomato to yellow and improve its traits.The breakthrough is important as it demonstrates that genome editing can be used in the country‚Äôs agricultural crops to improve traits without using the ...
3/24/2021 Kochi firm develops technology to use genome editing in crops without modifying genes thehindubusinessline.com ó Changes tomato colour into yellow using Nobel Prize winners‚Äô methodA group of scientists at AgriGenome Labs in Kerala‚Äôs Kochi city has used the popular genome editing technology - CRISPR Cas9 - to change the colour of tomato to yellow and improve its traits.The breakthrough is important as it demonstrates that genome editing can be used in the country‚Äôs agricultural crops to improve traits without using the ...
3/6/2021 Pioneer of CRISPR genome-editing technology, Jennifer Doudna, opens inaugural Lemley Family Leadership Lecture Series uwire.com Pioneer of CRISPR genome-editing technology, Jennifer Doudna, opens inaugural Lemley Family Leadership Lecture Series Posted on March 5, 2021Nobel Prize winner Jennifer Doudna, who co-invented CRISPR-Cas9 genome editing technology , joined President Christina Paxson P’19 for a virtual conversation on CRISPR’s wide-ranging applications and its ethical implications in medicine and beyond.Doudna and collaborator Emmanuelle Charpentier received the 2020 Nobel Prize in Chemistry for ...
3/3/2021 ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical financialbuzz.com ERS Genomics Limited, which was formed to provide broad access to foundational CRISPR/Cas9 intellectual property today announced the signing of a license agreement with Otsuka Pharmaceutical Co. Ltd. (Otsuka). The license grants Otsuka access to CRISPR/Cas9 genome editing technology for its internal research and development initiatives to address areas of unmet medical need.ERS Genomics holds an exclusive worldwide license from co-founder and recent Nobel prize winner ...
3/2/2021 Scientists Use Lipid Nanoparticles to Precisely Target Gene Editing to the Liver tufts.edu EmailThe genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically targeted to the gene, tissue and organ that needs treatment. Scientists at Tufts University and the Broad Institute of Harvard and MIT have developed unique nanoparticles comprised of lipids -- fat ...
3/2/2021 Unique nanoparticles can package and deliver gene-editing machinery to the liver news-medical.net The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically targeted to the gene, tissue and organ that needs treatment. Scientists at Tufts University and the Broad Institute of Harvard and MIT have developed unique nanoparticles comprised of lipids -- fat molecules ...
3/1/2021 Scientists use lipid nanoparticles to precisely target gene editing to the liver sciencedaily.com ... specific tissues and organs, demonstrating the treatment of high cholesterol by targeting genes in the liver of mice, reducing cholesterol for over 3 months (and potentially more) with one treatment. Share: FULL STORY The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively ...
3/1/2021 Scientists use lipid nanoparticles to precisely target gene editing to the liver Phys Org ... levels of LDL "bad" cholesterol in the blood. Together with earlier studies demonstrating delivery to the brain or T cells suggest a future possibility of highly targeted gene editing therapies. Credit: Tufts UniversityThe genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively ...
3/1/2021 Using lipid nanoparticles to precisely target gene editing to the liver nanowerk.com Mar 01, 2021 Using lipid nanoparticles to precisely target gene editing to the liver ( Nanowerk News ) The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically targeted to the gene, tissue and organ that needs treatment. Scientists at Tufts University and ...
2/28/2021 J.P. Morgan Downgrades Editas Medicine (EDIT) to Sell analystratings.com ... Äôs market cap is currently $2.76B and has a P/E ratio of -28.70. The company has a Price to Book ratio of 7.08.Editas Medicine, Inc. engages in the development and commercialization of genome editing technology . Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and ...
2/26/2021 Raymond James Initiates a Hold Rating on Editas Medicine (EDIT) markets.co ... Äôs market cap is currently $2.81B and has a P/E ratio of -28.40. The company has a Price to Book ratio of 7.00.Editas Medicine, Inc. engages in the development and commercialization of genome editing technology . Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and ...
2/9/2021 Hoxton Farms raises ÂŁ2.7M seed to produce animal fat without animals TechCrunch ... started the company with longtime school friend Dr Max Jamilly, who has two degrees in biotechnology and a PhD in synthetic biology (the pair met at pre-school). “I spent my PhD using a genome editing technology called CRISPR to discover better treatments for children’s leukaemia,” says Jamilly. “Along the way, I learnt how to grow complex cells at scale — a fundamental part of the scientific challenge ...
2/9/2021 Hoxton Farms raises £2.7M seed to produce animal fat without animals Yahoo News ... started the company with longtime school friend Dr Max Jamilly, who has two degrees in biotechnology and a PhD in synthetic biology (the pair met at pre-school). “I spent my PhD using a genome editing technology called CRISPR to discover better treatments for children's leukaemia,” says Jamilly. “Along the way, I learnt how to grow complex cells at scale -- a fundamental part of the scientific challenge that we ...
2/9/2021 Hoxton Farms raises £2.7M seed to produce animal fat without animals google.com ... started the company with longtime school friend Dr Max Jamilly, who has two degrees in biotechnology and a PhD in synthetic biology (the pair met at pre-school). “I spent my PhD using a genome editing technology called CRISPR to discover better treatments for children’s leukaemia,” says Jamilly. “Along the way, I learnt how to grow complex cells at scale — a fundamental part of the scientific challenge ...